A case of ecthyma during therapy with an epidermal growth factor receptor inhibitorMIZUNO, Takashi; TANEGASHIMA, Tomohiko; SUZUKI, Aki et al.EJD. European journal of dermatology. 2014, Vol 24, Num 4, pp 511-512, issn 1167-1122, 2 p.Article

Epidermal Growth Factor Receptor in the Prawn Macrobrachium rosenbergii: Function and Putative Signaling CascadeSHARABI, Omri; VENTURA, Tomer; MANOR, Rivka et al.Endocrinology (Philadelphia). 2013, Vol 154, Num 9, pp 3188-3196, issn 0013-7227, 9 p.Article

Downregulation of EGFR by a novel multivalent nanobody-liposome platformOLIVEIRA, Sabrina; SCHIFFELERS, Raymond M; VAN DER VEEKEN, Joris et al.Journal of controlled release. 2010, Vol 145, Num 2, pp 165-175, issn 0168-3659, 11 p.Article

Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647GENDREAU, Steven B; VENTURA, Richard; JACKMAN, Lisa et al.Clinical cancer research. 2007, Vol 13, Num 12, pp 3713-3723, issn 1078-0432, 11 p.Article

Cetuximab : Significant clinical value after platinum failureJournal of cancer research and clinical oncology. 2006, Vol 132, pp 11-13, issn 0171-5216, 3 p., SUP3Conference Paper

Rationale for cetuximab in SCCHNYARDEN, Yosef.Journal of cancer research and clinical oncology. 2006, Vol 132, pp 4-5, issn 0171-5216, 2 p., SUP3Conference Paper

CTEN Prolongs Signaling by EGFR through Reducing Its Ligand-Induced DegradationHONG, Shiao-Ya; SHIH, Yi-Ping; TIANHONG LI et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 16, pp 5266-5276, issn 0008-5472, 11 p.Article

Spatial control of EGF receptor activation by reversible dimerization on living cellsCHUNG, Inhee; AKITA, Robert; VANDLEN, Richard et al.Nature (London). 2010, Vol 464, Num 7289, pp 783-787, issn 0028-0836, 5 p.Article

Slug/Snai2 Is a Downstream Mediator of Epidermal Growth Factor Receptor-Stimulated ReepithelializationKUSEWITT, Donna F; CHOI, Changsun; NEWKIRK, Kimberly M et al.Journal of investigative dermatology. 2009, Vol 129, Num 2, pp 491-495, issn 0022-202X, 5 p.Article

EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomesGRANDAL, Michael V; ZANDI, Roza; PEDERSEN, Mikkel W et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 7, pp 1408-1417, issn 0143-3334, 10 p.Article

Epidermal growth factor receptor activation : How exon19 and 21 mutations changed our understanding of the pathwayROSELL, Rafael; TARON, Miquel; REGUART, Noemi et al.Clinical cancer research. 2006, Vol 12, Num 24, pp 7222-7231, issn 1078-0432, 10 p.Article

Novel Role of MDA-9/Syntenin in Regulating Urothelial Cell Proliferation by Modulating EGFR SignalingDASGUPTA, Santanu; MENEZES, Mitchell E; DAS, Swadesh K et al.Clinical cancer research (Print). 2013, Vol 19, Num 17, pp 4621-4633, issn 1078-0432, 13 p.Article

Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsAGERO, Anna Liza C; DUSZA, Stephen W; BENVENUTO-ANDRADE, Cristiane et al.Journal of the American Academy of Dermatology. 2006, Vol 55, Num 4, pp 657-670, issn 0190-9622, 14 p.Article

Novel combinations based on epidermal growth factor receptor inhibitionADJEI, Alex A.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4446s-4450s, 2Conference Paper

Dissociation of Epidermal Growth Factor Receptor and ErbB2 Heterodimers in the Presence of Somatostatin Receptor 5 Modulate Signaling PathwaysKHARMATE, Geetanjali; RAJPUT, Padmesh S; WATT, Heather L et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 3, pp 931-945, issn 0013-7227, 15 p.Article

Monoubiquitinylation Regulates Endosomal Localization of Lst2, a Negative Regulator of EGF Receptor SignalingMOSESSON, Yaron; CHETRIT, David; WARDEN, Yosef et al.Developmental cell. 2009, Vol 16, Num 5, pp 687-698, issn 1534-5807, 12 p.Article

Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy. CommentaryDEWITT, Christine A; SIROY, Alan E; STONE, Stephen P et al.Journal of the American Academy of Dermatology. 2007, Vol 56, Num 3, issn 0190-9622, 500-505, 514-517 [10 p.]Article

The EGFR Is Required for Proper Innervation to the SkinMAKLAD, Adel; NICOLAI, Jodi R; BICHSEL, Kyle J et al.Journal of investigative dermatology. 2009, Vol 129, Num 3, pp 690-698, issn 0022-202X, 9 p.Article

HerceptinSHEPARD, H. M; JIN, P; SLAMON, D. J et al.Handbook of experimental pharmacology. 2008, Vol 181, pp 183-219, issn 0171-2004, 37 p.Article

Importance of EGFR/ERCC1 Interaction Following Radiation-Induced DNA DamageLICCARDI, Gianmaria; HARTLEY, John A; HOCHHAUSER, Daniel et al.Clinical cancer research (Print). 2014, Vol 20, Num 13, pp 3496-3506, issn 1078-0432, 11 p.Article

Traitements de 2^e et 3^e ligne: chimiothérapie ou TKI de l'EGFR ? = Second and third lines therapies: chemotherapy or EGFR TKI?BUNEL, V; GREILLIER, L.Revue des maladies respiratoires actualités (Print). 2014, Vol 6, Num 2, pp 132-135, issn 1877-1203, 4 p.Article

Treating Patients With EGFR-Sensitizing Mutations: First Line or Second Line—Is There a Difference?MOK, Tony; YANG, Jin-Ji; LAM, Kwok-Chi et al.Journal of clinical oncology. 2013, Vol 31, Num 8, pp 1081-1088, issn 0732-183X, 8 p.Article

Effect of the maternofetal and milk transfer of the anti-epidermal growth factor receptor monoclonal antibody 7A7 in miceGONZALEZ, J. E; LEON, M; HERNANDEZ, I et al.Placenta (Eastbourne). 2011, Vol 32, Num 6, pp 470-474, issn 0143-4004, 5 p.Article

Role of Cell Cycle in Epidermal Growth Factor Receptor Inhibitor-Mediated RadiosensitizationAHSAN, Aarif; HINIKER, Susan M; DAVIS, Mary A et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 12, issn 0008-5472, 5108-5114 [7 p.]Article

Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology : Hopes and DisappointmentsBRANDES, Alba A; FRANCESCHI, Enrico; TOSONI, Alicia et al.Clinical cancer research. 2008, Vol 14, Num 4, pp 957-960, issn 1078-0432, 4 p.Article